Responses to parliamentary questions
Question from Deputy Ken O'Flynn - PQ 15880-26
Deputy O'Flynn asked about the reimbursement to tirzepatide and semaglutide. Read the HSE response.
From: Communications and public affairs
Published: February 2026
Updated: March 2026
Documents
Question from Deputy Ken O'Flynn - PQ 15880-26
PDF, 437KB, 2 pages
Summary
To ask the Minister for Health the estimated number of adults nationally who meet the clinical eligibility thresholds outlined in the completed HTAs for tirzepatide for diabetes and weight management indications; the estimated number of adolescents who would meet the subpopulation criteria proposed for semaglutide reimbursement; whether her Department has been advised of projected uptake rates; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it